spec sheet8 rows
Muscarine The fungal alkaloid that muscarinic receptors are named after; it has no therapeutic use and matters today as the toxin behind Inocybe and Clitocybe mushroom poisoning.
- A reference agonist against which the muscarinic receptor class was originally defined
- Still used as an analytical standard in mushroom toxicology
- Profuse sweating
- Salivation and lacrimation
- Miosis and blurred vision
- Abdominal cramps, vomiting and diarrhoea
- Bradycardia and hypotension
- Bronchial secretion and wheeze
- Syncope and, in severe poisoning, circulatory collapse
Overview
Historically enormous and clinically small. Muscarine defined a receptor family and then contributed almost nothing else; it is a reference standard in the laboratory and a hazard in the woods. The single most useful thing to know about it is negative: it is not what makes fly agaric psychoactive, and repeating that it is has probably sent more people looking for the wrong antidote than any other error in popular mycology.
- Muscarine is not what makes Amanita muscaria psychoactive. A review of the mushroom's chemistry and toxicology identifies ibotenic acid and muscimol as the active components [3]; ibotenic acid is an agonist at NMDA and metabotropic glutamate receptors [10] and muscimol binds GABA-A receptors with low nanomolar affinity [11], so neither works through muscarinic receptors at all. Measured ibotenic acid and muscimol in fly agaric caps run to thousands of parts per million [4], while muscarine has long been cited at about 3 parts per million and was measured in 2025 at 40 to 430 parts per million [2]. The mushrooms that actually cause muscarine poisoning are Inocybe and Clitocybe species [1].
- Some muscarine-producing mushrooms store the toxin in a disarmed form. In Clitocybe rivulosa the major natural product is 4'-phosphomuscarine, which activates the M3 receptor only weakly; cellular injury and unspecific esterase cleavage liberate free muscarine from it [5].
Mechanism
Muscarine is a non-selective at receptors, and it is the compound against which that entire receptor class was defined, as distinct from the nicotine-sensitive class. Against the agonist radioligand [3H]oxotremorine-M its affinity sits in the tens of nanomolar across subtypes: about 56 nM at human M1, 23 nM at human M4 and 8.3 nM at native rat cardiac muscarinic receptors, while the same rat preparation measured against the radioligand [3H]QNB gives about 4.4 uM [9].
That roughly 500-fold split is the ordinary signature of an that binds the G-protein-coupled receptor state far better than the uncoupled one, and it is why a single muscarine affinity figure means little without the radioligand attached to it. Structurally it is unlike the other classic cholinomimetics: a hydroxylated tetrahydrofuran carrying a quaternary trimethylammonium group, with no ester linkage anywhere, so cholinesterase has nothing to cleave and the molecule persists until it is excreted. The permanent positive charge also keeps it out of the brain, which is why poisoning presents as a purely peripheral parasympathetic event in a patient whose sensorium stays clear [1].
receptor fingerprint
M1 (CHRM1)Agonist
M2 (CHRM2)Agonist
M4 (CHRM4)Agonist
Native receptors, rat heartAgonist
M3 (CHRM3)Agonist
Safetyrisks and cautions, not medical advice
Muscarine poisoning is the cholinergic toxidrome with everything central subtracted. Onset is typically 15 minutes to 2 hours after the meal, and the picture is unopposed parasympathetic drive: sweating, salivation, lacrimation, miosis, blurred vision, abdominal pain, vomiting and diarrhoea, bradycardia or tachycardia, hypotension and syncope, with bronchial secretion and bronchoconstriction in heavier exposures [1]. Because muscarine acts only at muscarinic receptors and does not enter the brain, atropine is a true antidote rather than a partial one, unlike its role in organophosphate poisoning where the nicotinic and central components remain.
In a case series of 14 patients with mycologically confirmed Inocybe ingestion, supportive care with intravenous fluids, antiemetics and 1 mg of intravenous atropine produced full recovery within 12 hours in every case [1]. Severe outcomes including circulatory collapse are described, and a 2024 study complicates dose estimation: Clitocybe rivulosa and two fibre cap species store much of their muscarine as 4'-phosphomuscarine, a phosphorylated form with only weak affinity for the M3 receptor that unspecific esterase cleavage releases as free toxin, so the free muscarine measured in an intact mushroom can understate what a poisoned person actually receives [5].
History
Muscarine was isolated from Amanita muscaria in the nineteenth century and gave its name both to the receptor class it activates and, by extension, to the muscarinic versus nicotinic division that still organises cholinergic pharmacology. The irony is that the mushroom it is named after barely contains it. English-language mycology has for decades repeated a 1950s figure of 0.0003 percent muscarine in fresh fly agaric; a 2025 HPLC-MS/MS analysis found a range of 0.004 to 0.043 percent, higher than the consensus but still low [2].
The mushrooms that actually poison people with muscarine are elsewhere: a confirmed Inocybe serotina poisoning in Ningxia measured 324 mg of muscarine per kilogram of mushroom [7], and newly described tropical species in the Inocybaceae have been measured in grams per kilogram [8], a concentration fly agaric does not reach. Surveys across the Inocybaceae show muscarine is not a single ancestral trait but arose independently several times within the family [6].
Reputation
Known to pharmacologists as an eponym, to emergency physicians as a toxidrome, and to almost nobody as a drug. It is also the subject of one of the most durable errors in popular writing about mushrooms, the assumption that muscarine is what makes fly agaric psychoactive; that mistake matters clinically, because it points toward atropine in a poisoning where atropine is the wrong answer and toward reassurance in the Inocybe poisonings where it is the right one.
Subjective profileweighing the evidence above
Historically enormous and clinically small. Muscarine defined a receptor family and then contributed almost nothing else; it is a reference standard in the laboratory and a hazard in the woods. The single most useful thing to know about it is negative: it is not what makes fly agaric psychoactive, and repeating that it is has probably sent more people looking for the wrong antidote than any other error in popular mycology.
Resources
This entry is here for reference.
Research
- 1992first citedIbotenic acid mediates neurotoxicity and phosphoinositide hydrolysis by independent receptor me…
- 2025most recentAn Examination of Cholinergic Symptoms Produced by the Fly Agaric Mushroom Amanita muscaria (Ag…
- 1.Mushroom poisoning from species of genus Inocybe (fiber head mushroom): a case series with exact species identification.
- 2.An Examination of Cholinergic Symptoms Produced by the Fly Agaric Mushroom Amanita muscaria (Agaricomycetes): Revisiting the Role of Muscarine.
- 3.Amanita muscaria: chemistry, biology, toxicology, and ethnomycology.
- 4.Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan.
- 5.The Fatal Mushroom Neurotoxin Muscarine is Released from a Harmless Phosphorylated Precursor upon Cellular Injury.
- 6.Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.
- 7.Mushroom poisoning from Inocybe serotina: A case report from Ningxia, northwest China with exact species identification and muscarine detection.
- 8.Two new Inosperma (Inocybaceae) species with unexpected muscarine contents from tropical China.
- 9.6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
- 10.Ibotenic acid mediates neurotoxicity and phosphoinositide hydrolysis by independent receptor mechanisms.
- 11.Lateral mobility and specific binding to GABA(A) receptors on hippocampal neurons monitored by fluorescence correlation spectroscopy.
- 12.Application to several suspected poisoning cases of a validated analytical method for the determination of muscarine in human biological matrices using liquid chromatography with high-resolution mass spectrometry detection.
12 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Is muscarine what makes fly agaric mushrooms psychoactive?
No. The effects of Amanita muscaria come from ibotenic acid and muscimol [3], which act at glutamate and GABA-A receptors [10] [11] rather than at muscarinic ones. Muscarine is present in fly agaric only in small amounts; the long-cited figure is about 3 parts per million and a 2025 analysis measured 40 to 430 parts per million [2]. The mushrooms that cause genuine muscarine poisoning are Inocybe and Clitocybe species [1].
What is the antidote for muscarine poisoning?
Atropine. Because muscarine acts only at muscarinic receptors and does not enter the brain, a muscarinic blocker covers the whole toxidrome rather than part of it. In a series of 14 patients with mycologically confirmed Inocybe poisoning, supportive care plus 1 mg of intravenous atropine gave full recovery within 12 hours in every case [1]. Poisoning is a medical emergency and this is a description of how it is treated, not a prescription.
Why does muscarine not affect the mind the way atropine or scopolamine do?
Atropine and scopolamine are tertiary amines that cross into the brain and can cause delirium. Muscarine carries a permanent positive charge and stays in the periphery, so poisoning produces a wet, cramping, slowed body and a clear head.
Why are muscarinic receptors named after a mushroom toxin?
Because muscarine and nicotine separated the two classes of acetylcholine receptor long before anyone could clone either. Compounds behaving like muscarine defined one class and compounds behaving like nicotine defined the other, and the names survived into the molecular era.
How long does muscarine poisoning last?
Symptoms typically start 15 minutes to 2 hours after eating the mushroom and resolve within about half a day with supportive care; in the Inocybe case series every patient had recovered fully within 12 hours [1]. The pharmacokinetics of muscarine in humans are still poorly characterised, and quantitative blood and urine methods have only recently been validated.
Adverse effects
- Profuse sweating
- Salivation and lacrimation
- Miosis and blurred vision
- Abdominal cramps, vomiting and diarrhoea
- Bradycardia and hypotension
- Bronchial secretion and wheeze
- Syncope and, in severe poisoning, circulatory collapse